Saroglitazar delivers positive Phase III results in rare liver disease PBC, U.S. filing planned 10 months ago ByJohnIn Pharma Industry UpdatesTop Stories
FDA approves Dupixent for chronic spontaneous urticaria in ages 12 and up 10 months ago ByJohnIn Breaking NewsFDA Approvals
FDA updates label for mavacamten after long-term studies show durable benefit in obstructive hypertrophic cardiomyopathy 10 months ago ByJohnIn BreakthroughsFDA ApprovalsResearch UpdatesTop Stories
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial 10 months ago ByJohnIn InvestmentsPeopleVenture Capital
EU Unveils Public Clinical Trial Map to Boost Transparency and Patient Access 10 months ago ByJohnIn Featured AnalysisTop Stories
WHO Sparks Global Clinical Trials Momentum with Forum to Fast-Track Innovation 10 months ago ByJohnIn BreakthroughsIndustry ConferencesResearch Updates
Australia Boosts Brain Cancer Research with $5.9 Million Grant for Innovative Chair 10 months ago ByJohnIn Biopharma HighlightsPartnershipsPeople
UK Sets Stage for Smoother Clinical Trials with New Law Expected by Mid-April 10 months ago ByJohnIn BreakthroughsClinical TrialsPeople
Emerging biotechs increasingly driving drug approvals, reshaping industry dynamics 10 months ago ByJohnIn Biopharma HighlightsClinical Trials
Precision Psychiatry Breakthrough: BH-200 Antidepressant Combined with Genetic Testing Delivers Strong Response in Major Depression Trial 10 months ago ByJohnIn Research UpdatesTop Stories
FDA approves novel immunotherapy combo for colorectal cancer and clears new surgery technology 10 months ago ByJohnIn DealsFDA ApprovalsResearch Updates
MHRA unveils first-ever analysis of UK clinical trial applications, offering new roadmap for research growth 10 months ago ByJohnIn Breaking NewsClinical TrialsFeatured Analysis
New clinical trial regulations take effect in the UK as pandemic case rates remain steady 10 months ago ByJohnIn Industry ConferencesPharma Industry UpdatesTop Stories
UK Unveils Major Push to Accelerate Clinical Trials and Health Data Access 10 months ago ByJohnIn Biopharma HighlightsFeatured AnalysisIndustry ConferencesResearch Updates
PTC Therapeutics reports promising Phase 2 results in Huntington’s disease program 10 months ago ByJohnIn Clinical TrialsFeatured AnalysisResearch UpdatesTop Stories
